Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease

Turkish Journal of Gastroenterology

Volumn 16, Issue 2, 2005, Pages 65-70

  Sariçam, Tülay ^a   Kircali, Baybora ^a   Köken, Tülay ^b  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antioxidant capacity; Lipid peroxidation; Non alcoholic fatty liver disease

Indexed keywords

CATALASE; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; ASPIRATION BIOPSY; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIPID PEROXIDATION; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL CIRCULATION; STEATITIS; TISSUE LEVEL;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CATALASE; FATTY LIVER; FEMALE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE;

EID: 22544455101     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Harrison SA, Kadakia S, Lang KA, et al. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002; 97: 2714-24.
2. Ludwig J, Viggiano TR, McGill DB, et al. Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
3. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-9.
4. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
5. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
6. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
7. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.
8. Angulo P. Nonalcoholic fatty liver disease. New Engl J Med 2002; 346: 1221-31.
9. Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002; 35: 746-52.
10. Pessayre D, Berson A, Fromenty B, et al. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57-69.
11. Pinto HC. Oxidative stress in alcoholic and non-alcoholic liver disease. In: Leuschner U (eds). Falk Symposium 121, steatohepatitis (NASH and ASH). Kluwer Academic Publishers and Falk Foundation 2001; 54-61.
12. Farrell GC, Robertson G, LeClercq I, et al. Inducible cytochromes P450 and lipid peroxidation in non-alcoholic steatohepatitis. In: Leuschner U (eds). Falk Symposium 121, steatohepatitis (NASH and ASH). Kluwer Academic Publishers and Falk Foundation 2001; 75-9.
13. Lu SC. Regulation of hepatic glutathione synthesis. Semin Liver Dis 1998; 18: 331-43.
14. Byron D, Miruk GY. Profile of an urban hospital-based practice. Hepatology 1996; 24: 813-5.
15. Jain SK, Pemberton PW, Smith A, et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002; 36: 805-11.
16. Yadav D, Hertan HI, Schweitzer P, et al. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol 2002; 97: 2634-9.
17. Leclercq IA, Farrell GC, Field J, et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000; 105: 1067-107.
18. Soltys K, Dikdan G, Koneru B. Oxidative stress in fatty livers of obese zucker rats: rapid amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology 2001; 34: 13-8.
19. Vendemiale G, Grattagliano I, Caraceni P, et al. Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 2001; 33: 808-15.
20. Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis II. Cytochrome P-450 enzymes and oxidative stress. Gastrointest Liver Physiol 2001; 281: 1135-9.
21. Loguercio C, De Girolamo V, De Sio I, et al. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 2001; 35: 568-74.
22. Ha EJ, Smith AM. Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle. J Am Coll Nut 2003; 1: 43-51.
23. Massafra C, Gioia D, Felice CD, et al. Gender-related differences in erythrocyte glutathione peroxidase activity in healthy subjects. Clin Endocrinol (Oxf) 2002; 5: 663-7.